Analgesics - South Korea

  • South Korea
  • In South Korea, the revenue generated in the Analgesics market in 2024 amounts to US$0.79bn.
  • This market is projected to experience an annual growth rate of 6.06% (CAGR 2024-2029).
  • When compared globally, the highest revenue is generated the in the United States, reaching US$7,243.00m in 2024.
  • Looking at the per person revenues in relation to the total population, in South Korea generates US$15.18 in 2024.
  • The South Korean market for analgesics in the OTC Pharmaceuticals market is experiencing a surge in demand for natural and herbal remedies.

Key regions: Canada, United States, United Kingdom, Australia, Germany

Region comparison

Analyst Opinion

The Analgesics market in South Korea has experienced significant growth in recent years, driven by changing customer preferences and local special circumstances.

Customer preferences:
South Korean consumers have shown a growing preference for over-the-counter (OTC) analgesics, which are easily accessible and do not require a prescription. This trend can be attributed to the increasing awareness and acceptance of self-medication among consumers. Additionally, the convenience of purchasing OTC analgesics from pharmacies, supermarkets, and online platforms has contributed to their popularity.

Trends in the market:
One of the key trends in the Analgesics market in South Korea is the rising demand for natural and herbal-based pain relief products. Consumers are becoming more health-conscious and are seeking alternatives to traditional analgesics that may have potential side effects. This has led to the introduction of a wide range of natural and herbal analgesics in the market, including products made from ingredients such as ginger, turmeric, and ginseng.Another trend in the market is the increasing focus on innovation and product differentiation. Manufacturers are constantly introducing new formulations, delivery systems, and packaging designs to attract consumers. For example, there has been a growing popularity of pain relief patches and creams that provide targeted relief to specific areas of the body. Additionally, some analgesics are being marketed as fast-acting or long-lasting, catering to the varying needs of consumers.

Local special circumstances:
South Korea has a rapidly aging population, which has contributed to the growth of the Analgesics market. As people age, they are more likely to experience chronic pain and require regular pain relief medication. This demographic shift has created a larger customer base for analgesic products, particularly those targeted at the elderly population.Another special circumstance in South Korea is the high prevalence of musculoskeletal disorders, such as arthritis and back pain. These conditions are common among both the elderly and younger population due to factors such as sedentary lifestyles and occupational hazards. As a result, there is a constant demand for analgesics to manage pain associated with these disorders.

Underlying macroeconomic factors:
The growing disposable income and improving healthcare infrastructure in South Korea have also contributed to the development of the Analgesics market. As people have more money to spend on healthcare and wellness products, they are willing to invest in high-quality analgesics to manage pain effectively. Furthermore, the availability of a wide range of analgesics at different price points allows consumers to choose products that suit their budget and preferences.In conclusion, the Analgesics market in South Korea is witnessing growth due to changing customer preferences, including a preference for OTC products and natural/herbal-based analgesics. The market is also driven by local special circumstances such as an aging population and a high prevalence of musculoskeletal disorders. Additionally, underlying macroeconomic factors such as increasing disposable income and improving healthcare infrastructure have contributed to the development of the market.


Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.


In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.


  • Revenue
  • Analyst Opinion
  • Key Players
  • Sales Channels
  • Global Comparison
  • Methodology
  • Key Market Indicators
Please wait


Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)